|
CDK12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.659400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.276200E-01 |
| Normal-vs-Stage2 |
5.652000E-01 |
| Normal-vs-Stage3 |
2.727600E-01 |
| Normal-vs-Stage4 |
3.935600E-01 |
| Stage1-vs-Stage2 |
3.304000E-01 |
| Stage1-vs-Stage3 |
1.212180E-01 |
| Stage1-vs-Stage4 |
3.191200E-01 |
| Stage2-vs-Stage3 |
7.906400E-01 |
| Stage2-vs-Stage4 |
6.258200E-01 |
| Stage3-vs-Stage4 |
7.339600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.399200E-01 |
| Normal-vs-AfricanAmerican |
5.544000E-01 |
| Normal-vs-Asian |
6.098400E-01 |
| Caucasian-vs-AfricanAmerican |
3.325000E-01 |
| Caucasian-vs-Asian |
5.830400E-01 |
| AfricanAmerican-vs-Asian |
3.296400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.800000E-01 |
| Normal-vs-Female |
4.918400E-03 |
| Male-vs-Female |
5.980000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.880800E-01 |
| Normal-vs-Extreme_Weight |
1.051820E-01 |
| Normal-vs-Obese |
2.715200E-01 |
| Normal-vs-Extreme_Obese |
4.957800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.301800E-01 |
| Normal_Weight-vs-Obese |
3.597000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.583200E-01 |
| Extreme_Weight-vs-Obese |
2.201500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.551800E-01 |
| Obese-vs-Extreme_Obese |
2.857200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.542500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.831900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.325820E-01 |
| Normal-vs-Age(81-100Yrs) |
7.583900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.065220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.416600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.613300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.401000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.083430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.357800E-01 |
| Normal-VS-Type2 PRCC |
5.088400E-01 |
| Normal-VS-KIRP CIMP |
1.128440E-02 |
| Normal-VS-Unclassified PRCC |
6.419800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.056000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.837700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.228100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.961400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.553700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.191360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.480800E-01 |
| Normal-vs-N1 |
3.805600E-02 |
| Normal-vs-N2 |
5.773800E-01 |
| N0-vs-N1 |
1.315700E-02 |
| N0-vs-N2 |
3.099200E-01 |
| N1-vs-N2 |
6.703400E-01 |
|
|
